Sixty Six Oilfield Services Inc (SSOF)

[JohnnyRothrock]

...wait isnt this huge?:

“Zimmerman BioPharmaceuticals has invested more than 7 years and $6 million in developing and patenting this process. Zimmerman’s biosimilar insulin has been fully validated in preclinical trials and testing. The company has received an FDA recommendation to seek approval through the accelerated 505(b)(2) NDA process.

Dr. Ron Zimmerman is the Founder and Chief Science Officer of Zimmerman BioPharmaceuticals. Dr. Zimmerman served as the Chief Scientist at Eli Lilly for more than 30 years. His career in the biopharma industry also includes 20 years of building and selling biopharmaceutical businesses, where he developed and patented processes that greatly improve insulin manufacturing. Dr. Zimmerman served as the co-founder and President of IPT, Inc., which sold to IVAX Corporation at a 500% internal rate of return (IRR). IVAX later sold to Teva Pharmaceutical Industries for $7.4 billion (Nasdaq: TEVA) “


Bueller? Bueller? Guys.....’aint ‘dis be huge? lol....i re-read that like 3 times.....THIS is the guy who SSOf may RM with Biologx .....as he sits as CEO of both right now.....and this “greatly improved insulin manufacturing”?

Does anyone know how big of a market insulin is!

Dude...this is insane.....then the lower SS here....700 mil OS?